Comparing HIV PrEP medications: Study explores hypertension risk in adults on TAF vs. TDF

The risk of hypertension and statin initiation in adults starting Human Immunodeficiency Virus Pre-exposure prophylaxis.

BioNTech and Duality Bio add another investigational drug to oncology partnership – Pharmaceutical Technology

BioNTech has reported a sharp decline in revenue in H1 2023, generating only €1.44bn ($1.59bn) in the six months compared to €9.57 bn($10.5bn) it generated

August 7, 2023

Aficamten shows promise in enhancing exercise capacity in patients with hypertrophic cardiomyopathy

Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms

May 13, 2024

Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed. – Biotech Investments

Eckert & Ziegler SE / Key word(s): Quarter Results/Preliminary Results Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year.

April 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.